DHR Health: Pioneering Alzheimer’s Treatment Breakthrough South of San Antonio

Translate to Spanish or other 102 languages!

Dr. R. Alejandro Cruz, DHR Health Neurologist. Photo Courtesy DHR Health
- Advertisement -

Edinburg, Texas: DHR Health, a leader in healthcare innovation, proudly announced today its groundbreaking achievement as the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved medication for the early treatment of Alzheimer’s disease. This milestone demonstrates their expertise and is a significant advancement in healthcare for the Rio Grande Valley.

Under the expert guidance of neurologist Dr. R. Alejandro Cruz and the dedicated team at the DHR Health Neuroscience Institute, comprehensive protocols have been meticulously developed for administering Leqembi. These protocols encompass every aspect of patient care, from initial assessments to laboratory testing, radiology procedures, and establishing a state-of-the-art infusion center.

“I am very proud of the hard work of our team at DHR Health. Being the first facility to provide this groundbreaking therapy for Alzheimer’s disease marks a new era of hope for our community,” said Dr. R. Alejandro Cruz, DHR Health Neurologist.

- Advertisement -

As the largest physician-owned hospital in the United States and a leading healthcare provider in the Rio Grande Valley, DHR Health is immensely proud to be at the forefront of Alzheimer’s disease treatment in South Texas. “This achievement represents our ongoing commitment to bringing innovative and advanced treatment options to our community. We are proud to provide world-class care close to home,” said Marissa Castañeda, Senior Executive Vice President at DHR Health.

Dr. Cruz explains that Alzheimer’s disease is a progressive brain disorder characterized by changes in the brain that lead to the accumulation of certain proteins. These changes cause the brain to shrink and brain cells to die, resulting in dementia, which manifests as a gradual decline in memory, thinking, behavior, and social skills. The introduction of Leqembi offers hope for those affected by this debilitating condition, with the potential to improve quality of life and slow disease progression.

DHR Health continues delivering exceptional care, announcing a new chapter in Alzheimer’s treatment for the Rio Grande Valley. If you or a loved one are affected by Alzheimer’s, we encourage you to take the next step. To learn more about this groundbreaking treatment or to make an appointment, please contact the DHR Health Neuroscience Institute at (956) 362-8500.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Edinburg Teams Up with Reserva Coffee Roasters for Premium Patient Experience

With the grand opening of Reserva Coffee Roasters’ newest café, the warmth and comfort of home are now just a brew away at South Texas Health System Edinburg (STHS) and STHS Children’s, helping create the perfect setting for connection, conversation and community for hospital visitors, staff and physicians.

McAllen Mayor Leads Public Push for Early Lung Cancer Detection

McAllen Mayor Javier Villalobos hosted a televised discussion on lung cancer awareness with pulmonologist Juan P. Rey Mendoza and retired McAllen Police Lieutenant Joel Morales to encourage Rio Grande Valley residents to seek screening and recognize the risks of delayed diagnosis.

Pharr Goes Purple: City Proclaims June 2026 as Alzheimer’s & Brain Awareness Month

The Pharr City Commission proclaimed June 2026 as Alzheimer’s & Brain Awareness Month, recognizing the millions of individuals, families, caregivers, and researchers affected by Alzheimer’s disease and other forms of dementia.

DHR Health Celebrates Graduating Class of Medical Residents, Fellows, and Pharmacy Residents

DHR Health proudly celebrated the accomplishments of its graduates from their Graduate Medical Education (GME) program during a special graduation ceremony held on June 13, 2026, at the Edinburg Conference Center at Renaissance.
- Advertisement -